EU gives CE mark approval to SARS-CoV-2 test for Coronavirus.- Thermo Fisher
Related news and insights
Ad26.COV2-S [recombinant] a single-dose coronavirus vaccine from Janssen, part of Johnson & Johnson, has been approved by the MHRA (UK) and is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.
Sanofi and GlaxoSmithKline plc (GSK) started enrolment in their Phase III clinical study to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine candidate.
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) has issued a positive scientific opinion following the referral of sotrovimab to the CHMP under Article 5(3) of Regulation 726/2004.